PAUL D RUBIN

CIK 1210905 · Chief Medical Officer · last filed 2026-04-03

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$15.32M

Companies

3

Total Filings

57

Lifetime Open-Market Net

-$2.48M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
BIOA Chief Medical Officer 5,437 $18.04 $98.1K -$1.46M 8 2026-04-03
Viridian Therapeutics, Inc.\DE (MGEN) Delisted EVP, Research & Development $0 3 2019-02-08
XOMA Sr. VP Clinical Dev. & CMO 364,217 $41.79 $15.22M -$1.01M 46 2016-03-22

Recent Filings · Page 5 of 6

57 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2013-07-01 XOMA Exer (M) +567 $2.0K EDGAR
2013-06-18 XOMA Mixed −2,870 $7.4K EDGAR
2013-05-29 XOMA Mixed +2,870 -$7.5K EDGAR
2013-05-21 XOMA Mixed −5,215 -$1.4K EDGAR
2013-04-19 XOMA Sell (S) −6,000 $0 EDGAR
2013-04-01 XOMA Exer (M) +1,498 $5.0K EDGAR
2013-03-27 XOMA Mixed +11,215 -$23.0K EDGAR
2013-03-01 XOMA Grant (A) $0 EDGAR
2013-01-02 XOMA Exer (M) +833 $1.9K EDGAR
2012-10-01 XOMA Exer (M) +542 $1.9K EDGAR
Showing 4150 of 57
Page 5 of 6
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.